Arterys Status
The company raised $30.06 million of Series B venture funding in a deal led by Temasek Holdings on November 3, 2017, putting the company's pre-money valuation at $52 million. GE Ventures, Varian Medical Systems, Northwell Ventures, NewYork-Presbyterian Ventures, Emergent Medical Partners, ORI Capital, DNA Capital and Fosun Capital Group also participated in the round.
Add a review